Department of Internal Medicine and Clinical Immunology, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama, Japan.
J Infect Chemother. 2010 Feb;16(1):72-5. doi: 10.1007/s10156-009-0020-5.
In Japan, the increasing incidence of β-lactum-resistant Haemophilus influenzae infections is of growing concern. We retrospectively studied whether the prevalence of β-lactamase-negative ampicillin-resistant strains of H. influenzae was influenced by chronic lung diseases. H. influenzae isolates, obtained from patients who were diagnosed with acute or chronic bronchitis, or acute exacerbation of chronic bronchitis in 2005, were studied. In addition to susceptibility testing, polymerase chain reaction (PCR) was performed for the detection of TEM-1 β-lactamase, and Asn526-Lys and Ser385-Thr amino acid substitutions in the ftsI gene encoding penicillin-binding protein-3 (PBP-3). The minimum inhibitory concentration values of β-lactams were found to be increased in isolates from patients with chronic bronchitis who had been repeatedly administered antibiotics. Genetic analysis using PCR suggested that this might be associated with a high frequency of β-lactamase-negative strains with mutations in PBP-3. The presence of β-lactum-resistant strains needs to be considered for patients with chronic bronchitis in whom H. influenzae is isolated as a causative pathogen.
在日本,β-内酰胺类耐药流感嗜血杆菌感染的发病率不断上升,这引起了越来越多的关注。我们回顾性研究了慢性肺部疾病是否会影响β-内酰胺酶阴性氨苄西林耐药流感嗜血杆菌菌株的流行率。我们研究了 2005 年被诊断为急性或慢性支气管炎或慢性支气管炎急性加重的患者的流感嗜血杆菌分离株。除了药敏试验外,还通过聚合酶链反应(PCR)检测 TEM-1β-内酰胺酶以及编码青霉素结合蛋白-3(PBP-3)的 ftsI 基因中的天冬酰胺 526-赖氨酸和丝氨酸 385-苏氨酸氨基酸取代。从反复接受抗生素治疗的慢性支气管炎患者的分离株中发现β-内酰胺类药物的最小抑菌浓度值升高。使用 PCR 的遗传分析表明,这可能与 PBP-3 突变的β-内酰胺酶阴性菌株的高频率有关。对于分离出流感嗜血杆菌作为病原体的慢性支气管炎患者,需要考虑存在β-内酰胺类耐药菌株。